Discussion on Ivermectin and Cancer Treatment

Have you ever seen those colorful ivermectin and fenbendazole

cancer dosing charts?

They're on Twitter, they're on Instagram, they're on Facebook.

There's all different kinds.

You know, they have different color schemes,

and they're just everywhere.

Well, every single one of those charts was stolen from me and

then altered and colored. And every time I see one, I, I have to

laugh because

I can actually tell how far that chart is removed from the original by the

number of spelling mistakes it has.

I think there's some of them that have misspelled ivermectin,

some of them have

misspelled fenbendazole. Uh, it's, it's pretty funny to see.

But the originals I put out on my Substack,

and I put together a dosing guide because

thousands of cancer patients were asking me, "What dose

do I take? How do I, you know, how do I take these repurposed drugs?

Uh, what's safe? You know, what might cause side effects?" And so I

initially put out those dosing charts on my Substack in twenty twenty-four,

and then we actually published the first,

uh, protocol guide for cancer patients, uh, in

September of twenty twenty-four, uh, and that protocol included

ivermectin, fenbendazole, and mebendazole.

So every single one of those charts is stolen from me and

altered. But,

uh, if you're really wondering about where the

dosing ideas came from,

you're gonna be shocked to learn, uh, that

these dosing guides came from actually the largest institutions

in the world.

The ivermectin dosing guide actually came from a researcher in

MD Anderson in Texas, uh, who was collaborating with Brazilian

researchers, uh, de Castro and colleagues.

And in twenty twenty, he published, um, a dosing

guide on ivermectin in three leukemia

patients, uh, children,

uh, who were given ivermectin

after they had failed chemotherapy, and they were progressing.

Now, this was, uh, acute myeloid leukemia, extremely aggressive, so

these children were gonna die in a matter of weeks.

Two of them were put into remission, at least for a number of months,

and, uh, they used ivermectin one milligram per

kilogram

up to six months for one child. These kids were thirteen years old,

eleven years old, and five years old.

Uh, interestingly, the thirteen and eleven-year-olds actually

were put into

remission. Uh, the five-year-old didn't respond.

The leukemia was just too aggressive.

The fenbendazole dosing comes from Stanford.

In twenty twenty-one,

uh, Chiang and colleagues at Stanford

University Medical Center,

uh, published a case series of three patients

who, again, had failed

multiple lines of chemotherapy,

had taken fenbendazole, a thousand milligrams per kilogram-- uh,

sorry, a thousand

milligrams, and, uh, all of them, uh, beat

stage four cancer. Uh, it was one kidney cancer and two

bladder cancers. So Stanford University for fenbendazole.

Mebendazole

is very interesting because

the dosing on mebendazole was actually published by Johns Hopkins,

again, another huge university.

And, uh, they actually looked

at a very wide variety of dosing in a phase one clinical

trial in, uh, brain cancer patients.

And they checked everything from fifteen

hundred milligrams up to twelve thousand milligrams a day and

found safety, uh, all the way up to twelve thousand

milligrams, and that's when

some patients started having, uh, elevated liver function tests.

So it's, it's amazing that,

you know, this

use of repurposed drugs that is considered so controversial

was actually developed by the biggest

universities in the world or the biggest cancer centers in the

world.

So again, ivermectin dosing developed by MD

Anderson,

fenbendazole dosing developed by Stanford, and mebendazole

dosing developed by Johns Hopkins.

And if you're wondering when this dosing was developed,

uh, ivermectin dosing was published by MD Anderson in twenty

twenty,

fenbendazole was published by Stanford University in twenty twenty-one,

and mebendazole, uh, was published by Johns

Hopkins, uh, also in twenty twenty.

So it's right when the COVID pandemic hit.

And I guarantee you, there's not a single oncologist

in the United States who has told their cancer patients

about this history of dosing of

these repurposed drugs, not a single one.

And that's what informed consent should be all about.